Professional direction and technical expertise: surgical treatment of posthepatitic cirrhosis and portal hypertension, diagnosis and treatment of primary liver cancer and various liver masses, diagnosis and treatment of bile duct stones, especially intrahepatic bile duct stones.
Papers and works:
He has published more than 40 papers in SCI, China series, core and other journals.
Protective effect of 1.a- lipoic acid on partial ischemia-reperfusion injury of rat liver II. Inhibitory effect of octreotide on the proliferation of hepatocellular carcinoma cells induced by transforming growth factor-a.
3. The effect of octreotide on human hepatocellular carcinoma cell smmc-772 1 TGF-A.
Science and technology award: 1, clinical research on interventional radiology treatment of portal hypertension, the first prize of Anhui scientific and technological achievements (1995) ranked second.
2. Clinical series of endoscopic diagnosis and treatment of biliary and pancreatic diseases. The first prize of scientific and technological progress in Anhui province (1996) ranked fifth.
The clinical application of hilar approach in the treatment of proximal cholangiocarcinoma won the second prize.
Subject undertaken: the effect of selective cox-2 inhibitor on metastasis and recurrence after resection of liver cancer, ranking first in the provincial education department in 2007.
Clinical and basic research on mimicry of hepatocyte angiogenesis: In 2007, the Provincial Science and Technology Department ranked third.